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Edited by Robert B. RussellAbstract The aim of this work was to provide an overview of
the genetics of human ageing to gain novel insights about the
mechanisms involved. By incorporating ﬁndings from model
organisms to humans, such as mutations that either delay or
accelerate ageing in mice, we constructed the gene networks
previously related to ageing: namely, the network related to
DNA metabolism and the network involving the GH/IGF-1 axis.
Gathering data about the interacting partners of these proteins
allowed us to suggest the involvement in ageing of a number of
proteins through a ‘‘guilt-by-association’’ methodology. To
organize our data, we developed the ﬁrst curated database of
genes related to human ageing: GenAge. With over 200 entries,
GenAge may serve as a reference database of genes related to
human ageing. Moreover, we rendered the ﬁrst proteomic
network map of human ageing, which suggests a relationship
between the genetics of development and the genetics of ageing.
Our work serves as a framework upon which a systems-biology
understanding of ageing can be developed. GenAge is freely
available for academic purposes at: http://genomics.senes-
cence.info/genes/.
 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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Despite its general interest not only to the academic com-
munity but to medicine and the public in general, human
ageing is a poorly understood biological problem [1]. Findings
in model organisms have shown that genes can regulate ageing
[2,3] and so ageing clearly has a strong genetic component [4].
Yet since studying a process with the duration of ageing in
humans is nearly impossible, it is unknown how these genes ﬁt
together and impact on human ageing. The only few genes
shown to inﬂuence human ageing are the genes responsible for
the so-called ‘‘progeroid syndromes’’ [5]. Therefore, partly
because of technical diﬃculties in studying ageing in humans,
partly because of the complexity of the ageing process, the
genetics of human ageing remain largely a mystery.
The aim of this work is to create a comprehensive overview
of the genetics of human ageing by incorporating ﬁndings from
model organisms to humans. Namely, mutations that either
delay [6] or accelerate [7] ageing in mice oﬀer clues on the* Corresponding author. Present address: Department of Genetics,
Harvard Medical School, 77 Avenue Louis Pasteur, Room 238,
Boston, MA 02115, USA. Fax: +1-617-432-6513.
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doi:10.1016/j.febslet.2004.07.006genetic mechanisms of mammalian ageing. Since discriminat-
ing causes from eﬀects of ageing is troublesome, genetic in-
terventions that alter the rate of ageing provide some of the
few clear hints on the genetics of ageing. Our rationale is that
by integrating these results, we may gain novel insights about
the mechanisms involved. In addition, by gathering data about
the interacting partners of these proteins, it may be possible to
ﬁnd additional clues about the players involved in these
pathways. Eventually, we wanted to render the ﬁrst genomic
and proteomic network maps of human ageing to serve as a
framework upon which a systems-biology understanding of
ageing can be developed. As a result of our eﬀorts, we devel-
oped the ﬁrst curated database of genes related to human
ageing: GenAge, which is freely available for academic pur-
poses at: http://genomics.senescence.info/genes/.2. Materials and methods
2.1. Gene selection
Great caution was taken to ensure that the selection of GenAge
entries was as unbiased as possible. Initially, the few genes that appear
to modulate ageing in humans, such as the progeroid genes [5], were
selected, as were those that appear to inﬂuence mammalian ageing [8].
This list of genes inﬂuencing mammalian ageing is available online
(http://genomics.senescence.info/genes/clues.html). Importantly, Ge-
nAge is not a database of health-promoting genes but rather a data-
base of genes related to the fundamental human ageing process, as
advocated before [1,4]. Consequently, care was taken to discriminate
between genes that aﬀect ageing and those that extend longevity by
enhancing overall health.
In a second phase, a number of entries were selected in a ‘‘guilt-by-
association’’ methodology: these consisted of proteins found highly
associated with proteins or pathways previously directly linked with
ageing. A functional clustering of pathways involved was also derived
to identify the pathways of interest (http://genomics.senescence.info/
genes/function.html), in line with previous reports [2].
Lastly, data from non-mammalian models was also employed. Since
GenAge only includes human genes, many entries in GenAge represent
human homologues of genes shown to aﬀect ageing in model organ-
isms. These were derived from a variety of sources such as AGEID [9],
as done before [2]. Yet given the diﬃculty in extrapolating results from
model organisms to human biology [10], GenAge is not a collection of
genes identiﬁed in model organisms, but an integrative database that
places each entry in the perspective of human biology. An extensive
literature review, present in GenAge, was performed to assess whether
genes found to aﬀect ageing in model organisms may also relate to
human ageing. If applicable, the following criteria were followed: (1)
the inﬂuence of the gene in the model organism’s ageing process; (2)
the degree of conservation of the gene and protein in humans (e.g., the
presence of 1:1 orthologues); (3) information on the phenotype re-
sulting from polymorphisms or mutations in the human homologue;
and (4) eﬀects on ageing of the genetic manipulation – e.g., overex-
pression or disruption – of the gene’s product(s) in mice. Given the
subjective nature of the methodology, an explanation as to why the
gene was selected is present in each GenAge entry (also see http://
genomics.senescence.info/genes/allgenes.php), which also allows usersation of European Biochemical Societies.
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diﬀerent ways.
2.2. Software and hardware
The GenAge database is implemented using the MySQL 4.0.15 re-
lational database management system. The query form Web pages are
created dynamically in PHP or CGI scripts written in the Perl pro-
gramming language. PathwayAssist 2.5 (Stratagene, La Jolla, CA) and
InterViewer 3.7 (Inha University, WI Lab, South Korea) layout al-
gorithms were used to analyse and visualise the protein–protein in-
teraction networks. To automate Medline searches and perform text
data-mining of abstracts, we used the Perl programming language; our
programs are freely available online for non-commercial purposes
(http://genomics.senescence.info/software/). Protein–protein interac-
tions were obtained from the Human Protein Reference Database [11]
and from both automated and manual Medline searches.3. Results and discussion
Genes that appear to modulate mammalian ageing, including
genes that may accelerate ageing in humans [5], served as basis
for our work. The full list of genes as well as the respective
references is available online (http://genomics.senescence.info/
genes/clues.html), as previously published [8]. In line with
previous eﬀorts [2], we grouped genes shown to aﬀect ageing in
model organisms into functional clusters. We then attempted to
reconstruct the gene networks inﬂuencing ageing by focusing
on speciﬁc pathways. The rationale behind constructing maps
of protein–protein interactions is that by taking a top-downFig. 1. Gene network of proteins thought to inﬂuence mammalian ageing wh
directly linked to ageing in mice (hexagons) as well as proteins associated w
protein interactions as they appear in GenAge. Layout computed using theview we may gain a better perspective of how networks work
[12].
3.1. Gene networks inﬂuencing ageing
Given that most genes extending life span in mice appear to
aﬀect the GH/IGF-1 axis [2,13], we wanted to reconstruct the
gene network involved. Genes belonging to this pathway and
shown to inﬂuence ageing in mice served as our ﬁrst selection:
IGF1R, GH1, IGF1, GHR, GHRHR, PIT1, and PROP1
[6,8]. Protein–protein interactions for these proteins were ob-
tained from the Human Protein Reference Database [11] as
well as automated searches of Medline using the software we
developed (see Section 2). This allowed us to suggest the in-
volvement of a number of proteins as ‘‘guilt-by-association’’
by choosing the interaction partners of the proteins under
study with the higher connectivity to the GH/IGF-1 pathway.
‘‘Guilt-by-association’’ genes included, not surprisingly, a
number of proteins previously associated with insulin signal-
ling, but also the STAT family, JUN, and two proteins in-
volved in lipid metabolism: NR3C1 and LRP2. Using these
proteins we could then derive a proteomic view of the GH/
IGF-1 axis, including proteins shown to inﬂuence ageing and a
number of additional proteins identiﬁed through our ‘‘guilt-
by-association’’ methodology (Fig. 1).
The signal transduction from the transcription factor
PROP1, passing through PIT1, to the key hormones GH1,
IGF-1, and INS is represented. Interestingly, the signalose eﬀect may derive from alterations of the GH/IGF-1 axis. Proteins
ith these (circles) are represented. Lines represent published protein–
PathwayAssist software 2.5 (Stratagene, La Jolla, CA).
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and the STAT family of signalling proteins. Moreover, SHC1
also appears to play a pivotal role in the pathway, which is
intriguing since p66shc, one of SHC1’s splice variants, has been
related to ageing in mice [14].
While the large majority of genes extending life span in mice
are related to the GH/IGF-1 axis, the large majority of genes
related to an accelerated ageing phenotype in mammals appear
to be related to DNA metabolism [8]. Consequently, we also
wanted to derive the gene network for these genes. The major
diﬀerence when compared to the study of the GH/IGF-1
pathway is that the DNA metabolism network includes both
genes related to ageing in mice and genes related to ageing in
humans. Thus, care was taken to give more importance to
genes related to human ageing. For instance, protein–protein
interactions up to two degrees of freedom were investigated for
proteins related to human ageing, while only one degree of
freedom was used for proteins related to ageing in mice.
Contrary to the GH/IGF-1 gene network, the connection be-
tween the diﬀerent DNA metabolism proteins suggested to
aﬀect ageing is not so obvious (Fig. 2). Not surprisingly, since
some of these proteins have been related to human ageing
directly, we selected many more proteins in our ‘‘guilt-by-
association’’ strategy. These represent possible players in the
pathways involved and include PCNA, PRKCA, TP53, and
ERCC6, which showed the higher connectivity.Fig. 2. Gene network of proteins thought to inﬂuence mammalian ageing w
linked to ageing in humans (squares) or mice (hexagons) as well as proteins
sociated with ageing in a non-mammalian organism is also present (triangle). L
GenAge. Layout computed using the PathwayAssist software 2.5 (StratagenIt is also possible to analyse such pathways to ﬁnd new
controlling nodes. For example, it is possible to quantify the
inﬂuence of each gene on ageing, either manually or by the
selection process, and then attempt to ﬁnd new regulatory
nodes. Based on the gene networks we constructed, which
obviously represent the current knowledge on these proteins
and thus may be inaccurate, a few proteins appear to play
pivotal roles. For instance, SHC1 appears to be pivotal in
connecting the diﬀerent aspects of the GH/IGF-1 pathway,
while TP53 and WRN also emerge as crucial in the DNA
metabolism network. Of course, each of these models is subject
to a variety of interpretations. For example, if one sees ageing
as an accumulation of damage, then DNA repair pathways
may allow researchers to choose new targets of study or even
predict ways to optimize DNA repair in animals to delay
ageing and cancer.
3.2. GenAge: a curated database of genes related to human
ageing
To organize our data and compile over 1000 bibliographical
references collected to support our results, we developed the
ﬁrst curated database of genes related to human ageing: Ge-
nAge. GenAge is a relational database featuring methods to
search and analyse genes or clusters of genes, study networks,
and derive pathways. For instance, it is possible to search
genes related to a certain function or present in a given cellularhose function has been linked to DNA metabolism. Proteins directly
associated with these (circles) are represented; one protein (CAT) as-
ines represent published protein–protein interactions as they appear in
e, La Jolla, CA).
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their choice and ﬁnd novel relations between the genes in-
volved. It is also possible to seek genes related to common
pathways through, for example, protein–protein interactions
and a number of visualization tools are available.
In GenAge, we incorporated genes found to aﬀect ageing in
humans and mice and the genes we identiﬁed through our
‘‘guilt-by-association’’ method. We also included a number of
genes for which experimental evidence is contradictory in their
association with ageing. For instance, some genes found to
aﬀect ageing in model organisms but unconﬁrmed in mammals
were selected and it is possible for users to discriminate be-
tween diﬀerent levels of selection (see Section 2). Through this
list of genes, we were able to derive the ﬁrst global view of the
protein interaction network related to human ageing (Fig. 3).
Of course, this global view gives us only a general impression
of the performance of the network and it will require graph-
theoretic methods for its analysis. Moreover, many putative
genes are included with the added complication that manyFig. 3. Global view of the protein interaction network in GenAge build 6 (22
protein interactions were selected. Lines represent published protein–protein
function of each protein as deducted from the literature: red, DNA repair a
and development; yellow, transcriptional regulation and signalling; orange,
green, apoptosis; grey, unknown or other. Layout computed using the Pathgenes are frequently expressed in distinct organs or tissues.
Even so, our results give insights into how the mechanisms of
ageing ﬁt together not as a collection of genes but like a
mechanistic process where changes in one aspect of the cellular
machinery aﬀect cellular proliferation and body homeostasis.
Although expected, it is gratifying to observe the topology of
the network with three large functional clusters: growth and
development on one end, DNA metabolism on the other end,
and signalling pathways in the middle. It remains a challenge,
however, to assess how the combination of all these factors
explains the age-related loss of function and increase in vul-
nerability which we call ageing.
Probably, the most striking ﬁnding from our protein inter-
action map is the apparent inﬂuence on human ageing of genes
involved in development. The suggestion that genes regulating
development may also regulate the pace of ageing is not new
[15]. Although premature, our results support such a connec-
tion between the genetic mechanisms regulating development
and ageing. Links between proteins aﬀecting ageing in model/05/2004). All entries in GenAge for which there are reported protein–
interactions as they appear in GenAge. Colour indicates the primary
nd replication (oval), and DNA condensation (hexagon); blue, growth
redox and oxidative regulation (hexagon) and stress response (oval);
wayAssist software 2.5 (Stratagene, La Jolla, CA).
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reported such as the association between p66shc and the fork-
head family [16] or the apparent connection between the GH/
IGF-1 pathway and development [13]. From GenAge, we
found consistent examples of this connection between devel-
opment and ageing, either directly or using our ‘‘guilt-by-
association’’ method. For instance, two of the HOX genes
have been included in GenAge due to their association with
pathways that appear to be involved in ageing: HOXB7 and
HOXC4. In fact, the possible role of HOX genes in ageing has
been proposed before [17]. One hypothesis is that the cascade
of events that regulates ontogeny fades away after sexual
maturity resulting in ageing. This would explain as to why the
mammalian ageing process appears as if timed by some un-
known mechanism [4].
3.3. Concluding remarks
Global and local networks such as those presented herein
provide a framework for researchers to investigate speciﬁc
signalling and regulatory pathways involved in human ageing.
They allow us to suggest other genes as possible players in
ageing through a ‘‘guilt-by-association’’ methodology and re-
veal pivotal nodes in the pathways involved. For example, in
yeast pathways highly connected proteins with a central role in
the network’s architecture are more likely to be essential than
proteins with only a small number of links to other proteins
[18]. While global maps (Fig. 3) will require a much more
detailed analysis, we may obtain testable biological insights if
we focus on smaller and more specialized subsystems [12].
Using a system-biology approach to the study of human age-
ing, local networks such as those derived for the GH/IGF-1
axis (Fig. 1) may be used to design experiments in animal
models. Given the large number of age-related changes and
players involved in ageing, the insights provided by GenAge
are a powerful ﬁrst step towards understanding the genomic
and proteomic aspects of human ageing.
In the post-genome era, research into human ageing is made
diﬃcult by the lack of a coherent view of the genetic mecha-
nisms of ageing [8]. GenAge oﬀers a powerful new set of tools
to understand the genetics of human ageing and provides the
ﬁrst glimpse of how the genome aﬀects ageing. In addition,
GenAge may serve as a reference database of genes related to
human ageing. At present there are over 200 manually curated
entries in GenAge (http://genomics.senescence.info/genes/allg-
enes.php), each featuring a combination of automatically ex-
tracted data – e.g., protein, open reading frame, and promoter
sequences – and manually curated information – e.g., a de-
scription of the gene’s relevance to human ageing and a se-
lection of literature references. Hyperlinks in each entry also
point the user to a variety of additional sources of information
for a total of roughly 2000 hyperlinks.
At present, GenAge is mostly derived from genetic pertur-
bations in animal models or inferred from human pathologies.
One future prospect is to include entries showing diﬀerential
expression during ageing. Yet interpreting diﬀerently expressed
genes during ageing is not straightforward [8,19], particularly
since our aim in GenAge is to identify genes that could play a
causative role in human ageing. Clearly, it is much more dif-ﬁcult to determine cause versus eﬀect in gene expression ex-
periments than in mouse knockouts [8]. Even so, it is our goal
to incorporate genes diﬀerently expressed with age and attempt
to understand the regulatory basis of those changes. Inte-
grating protein–protein interactions with gene expression, as
well as other types of data, will allow us a better understanding
of the network topology of human ageing.
GenAge is located at the Human Ageing Genomic Re-
sources, which also include data-mining tools, software, and
AnAge, a database of, where available, species longevity,
phylogeny, metabolic rate, and ageing rate. Given that iden-
tifying the genes that determine the diﬀerent rates of ageing
amongst organisms is a major endeavour [2,4], AnAge is a
unique resource in the comparative biology of ageing with
over 2000 organisms listed. GenAge is freely available for
academic purposes (http://genomics.senescence.info/genes/) at
the Human Ageing Genomic Resources (http://genomics.
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